Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer
[摘要]
[发布日期] 2022-12-13 [发布机构]
[效力级别] [学科分类]
[关键词] Trastuzumab;in;Nuclear Translocation Sequence (NLS);Kit;Good Manufacturing Practices (GMP);Meitner-Auger electrons;Imaging;Radioimmunotherapy [时效性]
